VVigilance Weekly공개 리포트 보기
← 이번 주 리포트
rivaroxaban우선순위 중간ICSR 검토기타

LITERATURE DETAIL · PMID 41776019

Andexanet alfa Reduces Hematoma Expansion Following Controlled Cortical Impact in Mice Pretreated with Rivaroxaban.

Andexanet alfa Reduces Hematoma Expansion Following Controlled Cortical Impact in Mice Pretreated with Rivaroxaban.

저자
Franziska Lieschke, Sarah Gelhard, Michelle Rosenthal-Rueckeis, Christian Grefkes, Ferdinand O Bohmann
저널
Neurocritical care
공개일
2026 Aug
연구 유형
기타
DOI
10.1007/s12028-026-02463-w

문헌 요약

With the introduction of andexanet alfa, a specific antidote is now available to address life-threatening bleeding associated with factor Xa inhibitors. In this study, we explore its use in an experimental model of traumatic brain injury (TBI), mimicking a closed head trauma under rivaroxaban-induced anticoagulation. Male C57BL6 mice were fed with rivarox…

PV 검토 포인트

개별 증례 가능성과 중대성, 예상성 및 중복 여부를 우선 검토합니다.

PubMed에서 원문 정보 보기